05860nam 22006495 450 991072893010332120230531183647.09783031300400(electronic bk.)978303130039410.1007/978-3-031-30040-0(MiAaPQ)EBC30558383(Au-PeEL)EBL30558383(OCoLC)1381095739(DE-He213)978-3-031-30040-0(BIP)089067253(PPN)270612742(CKB)26816395400041(EXLCZ)992681639540004120230531d2023 u| 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierPotency Assays for Advanced Stem Cell Therapy Medicinal Products /edited by Jorge S. Burns1st ed. 2023.Cham :Springer International Publishing :Imprint: Springer,2023.1 online resource (226 pages)Advances in Experimental Medicine and Biology,2214-8019 ;1420Print version: Burns, Jorge S. Potency Assays for Advanced Stem Cell Therapy Medicinal Products Cham : Springer International Publishing AG,c2023 9783031300394 The Art of Cell Therapy -- Scope and Applicability of Autologous Cell Therapies -- Scale and Accessibility of Allogeneic Cell Therapies -- Acellular Stem Cell Products. Potency Assays: The Buggy Boo of Stem Cell Therapy -- Potency Assay Development: A Keystone for Clinical Use -- Quantifying Critical Quality Attributes -- Advanced Technologies for Potency Assay Measurement -- Potency Quality by Design: Tailoring for Specific Therapy -- Contract Research Organizations Expediting Therapeutic Availability -- Regulatory Authority Perspectives for Potency Release Criteria -- Illustrative Potency Assay Examples from Approved Therapies -- The Integrity of Potency Assays and Safe Intervention -- The Evolving Landscape of Potency Assays.This volume of the Springer book series Advances in Experimental Medicine and Biology covers potency assays, one of the most complex yet fundamental evaluations that critically influence stem cell regenerative medicine. Developing potency assays for cell-based medicinal products comes with numerous challenges due to the highly specialised nature of the application and purpose. This book provides the reader with the knowledge necessary to understand issues governing the successful development of potency assays, highlighting an international outlook of how the various challenges raised are being managed. Stakeholders concerned with potency assay development range from patient and clinician to contract research organisations, small and medium enterprise, regulatory authorities and even politicians. The value of potency assays is poised to increase given the inevitable watershed as early-stage clinical trials addressing safety progress to trials testing efficacy. Contributors from clinical, academic, industrial and regulatory sectors establish a broad point of view for guidance and timely debate. Potency assays require extensive collaboration across disciplines and sectors, as well as compromise and the authors aim to constructively address the many key aspects involved. Potency assays provide a quantitative measure of the biological activity of advanced therapy medicinal products (ATMPs) and thus are required for their market authorization. As the pace of ATMP development accelerates, the need to develop specific, accurate, and robust potency assays for each product is also accelerating. The volume Potency Assays for Stem Cell Advanced Therapy Medicinal Products presents a broad outlook on the development, quality attributes, and implementation of potency assays for ATMPs. The first few chapters introduce a nuanced historical perspective on the science of potency assay development, describe specific quality attributes of an idealized potency assay, indicate pitfalls associated with developing such assays for ATMPs, and review guidance recommended by regulatory authorities on assay suitability for product approval. Subsequent chapters highlight efforts to develop potency assays for specific ATMPs, including skeletal stem cells, mesenchymal stromal cells, extracellular vesicles, CAR T-cells, and discuss emerging technologies/platforms for potency assay design. The volume concludes with a chapter reviewing potency assays used for the release of commercial ATMP products, which amalgamates information contained in previous chapters. Overall, the knowledge contributed from leading authorities in both academia and industry is an ideal resource for technicians, scientists, clinicians, process engineers, and regulators working with ATMPs. —Donald G. Phinney, PhD Professor, Department of Molecular Medicine, Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology .Advances in Experimental Medicine and Biology,2214-8019 ;1420Stem cellsRegenerative medicineMedical microbiologyStem Cell BiologyRegenerative Medicine and Tissue EngineeringMedical MicrobiologyBiologyScienceStem cells.Regenerative medicine.Medical microbiology.Stem Cell Biology.Regenerative Medicine and Tissue Engineering.Medical Microbiology.616.02774616.02774Burns Jorge S1365625Burns Jorge S.edtMiAaPQMiAaPQMiAaPQ9910728930103321Potency Assays for Advanced Stem Cell Therapy Medicinal Products3387802UNINA